• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文学位 >A review of the Malaria Chemoprophylaxis Compliance Program at ExxonMobil Corporation.
【24h】

A review of the Malaria Chemoprophylaxis Compliance Program at ExxonMobil Corporation.

机译：埃克森美孚公司对疟疾化学预防合规计划的审查。

获取原文
获取原文并翻译 | 示例
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

ExxonMobil, a Fortune 500 oil and gas corporation, has a global workforce with employees assigned to projects in areas at risk for infectious diseases, particularly malaria. As such, the corporation has put in place a program to protect the health of workers and ensure their safety in malaria endemic zones. This program is called the Malaria Control Program (MCP). One component of this program is the more specific Malaria Chemoprophylaxis Compliance Program (MCCP), in which employees enroll following consent to random drug testing for compliance with the company's chemoprophylaxis requirements. Each year, data is gathered on the number of employees working in these locations and are selected randomly and tested for chemoprophylaxis compliance. The selection strives to test each eligible worker once per year. Test results that come back positive for the chemoprophylaxis drug are considered "detects" and tests that are negative for the drug and therefore show the worker is non-compliant at risk for severe malaria infection are considered "non-detect".;The current practice report used aggregate data to calculate statistics on test results to reflect compliance among both employees and contractors in various malaria-endemic areas. This aggregate, non-individualized data has been compiled and reflects the effectiveness and reach of ExxonMobil's Malaria Chemoprophylaxis Compliance Program. In order to assess compliance, information on the number of non-detect test results was compared to the number of tests completed per year. The data shows that over time, non-detect results have declined in both employee and contractor populations, and vary somewhat by location due to size and scope of the MCCP implemented in-country. Although the data indicate a positive trend for the corporation, some recommendations have been made for future implementation of the program.
机译：埃克森美孚（ExxonMobil）是一家《财富》 500强公司，在全球范围内拥有一支员工队伍，其员工被分配到具有传染病，尤其是疟疾风险的地区开展项目。因此，该公司已制定了一项计划，以保护工人的健康并确保他们在疟疾流行区的安全。该程序称为疟疾控制程序（MCP）。该计划的一个组成部分是更具体的疟疾化学预防遵守计划（MCCP），在该计划中，员工在同意接受随机药物测试以符合公司的化学预防要求之后进行注册。每年，都会收集有关在这些地点工作的员工数量的数据，并随机选择这些数据并测试其化学预防依从性。该选拔努力每年对每个合格的工人进行一次测试。化学预防药物阳性的检测结果被认为是“检测到”，而对该药物阴性的检测结果被认为是“未检测到”，表明该工人不符合严重疟疾感染风险的检测结果。报告使用汇总数据来计算测试结果的统计数据，以反映员工和承包商在各个疟疾流行地区的合规情况。这些汇总的非个性化数据已经汇总，反映了埃克森美孚公司的疟疾化学预防合规计划的有效性和覆盖面。为了评估合规性，将未检测到的测试结果数量的信息与每年完成的测试数量进行了比较。数据显示，随着时间的推移，由于在国内实施的MCCP的规模和范围，员工和承包商人口的未发现结果都在下降，并且因位置而异。尽管数据表明该公司有良好的发展趋势，但已为该计划的未来实施提出了一些建议。

著录项

  • 作者

    Brown, Amanda.;

  • 作者单位

    The University of Texas School of Public Health.;

  • 授予单位 The University of Texas School of Public Health.;
  • 学科 Health Sciences Occupational Health and Safety.
  • 学位 M.P.H.
  • 年度 2011
  • 页码 31 p.
  • 总页数 31
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号